CONOCOPHILLIPS (COP)       99.75  +1.82 (+1.86%)

99.75  +1.82 (+1.86%)

US20825C1045 - Common Stock - After market: 99.74 -0.01 (-0.01%)


Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to COP. COP was compared to 385 industry peers in the Oil, Gas & Consumable Fuels industry. COP scores excellent points on both the profitability and health parts. This is a solid base for a good stock. COP is not valued too expensively and it also shows a decent growth rate. COP also gives a nice dividend, which makes it suited for dividend investing!.




Profitability

Profitability Rating

7

COP has a Return On Assets of 19.91%. This is better than the industry average of 12.98%.
COP has a Return On Equity of 38.91%. This is better than the industry average of 28.11%.

COP has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for COP.
COP has a Profit Margin of 23.80%. This is comparable to the industry average of 26.04%.
VS Industry

ROA (19.91%) VS Industry: 73% outperformed.

0.06
1,708.00

ROE (38.91%) VS Industry: 69% outperformed.

0.30
19,161.80

Profit Margin (23.8%) VS Industry: 44% outperformed.

0.07
334.14

Valuation

Valuation Rating

5

With a Price/Earnings Ratio of 7.39, the valuation of COP can be described as very cheap.
With a Forward Price/Earnings Ratio of 9.26, the valuation of COP can be described as very reasonable.
COP's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a price book ratio of 2.53, COP is valued correctly.

Compared to an average industry Enterprise Value to EBITDA ratio of 3.70, COP is valued in line with its industry peers.
COP's Price/Earning Ratio is slightly more expensive than the industry average, which is at 5.76.
Compared to an average industry price book ratio of 1.45, COP is valued more expensive than its industry peers.
VS Industry

Price/Earnings (7.39) VS Industry: 38% outperformed.

4,750.00
0.01

Price/Book (2.53) VS Industry: 27% outperformed.

3,984.80
0.04

Enterprise Value/ EBITDA (3.72) VS Industry: 49% outperformed.

227.31
0.12

Growth

Growth Rating

5

COP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 124.83%, which is quite impressive.
COP shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 79.20% yearly.
Looking at the last year, COP shows a very strong growth in Revenue. The Revenue has grown by 71.28%.
The Revenue has been growing by 21.57% on average over the past 5 years. This is a very strong growth!

Based on estimates for the next 5 years, COP will show a decrease in Earnings Per Share. The EPS will decrease by -5.22% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
Based on estimates for the next 5 years, COP will show a very negative growth in Revenue. The Revenue will decrease by -12.90% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS79.2% 55.47% 124.83% -20.11% -10.37% -11.74% -5.22%
Revenue21.57% 34.27% 71.28% -13.91% -8.08% -9.67% -12.9%

Health

Health Rating

8

COP is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.17.
COP is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.01.
COP has an Altman-Z score of 4.18. This indicates that COP is financially healthy and little risk of bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 2.05, COP is in better financial health than the average industry peer.

COP has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for COP.
COP has a Current Ratio of 1.46. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Quick Ratio of 1.36. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
The Debt to Equity ratio of COP is in line with the industry averages.
VS Industry

Debt/Equity (0.34) VS Industry: 43% outperformed.

78.08
0.00

Quick Ratio (1.36) VS Industry: 63% outperformed.

0.00
279.52

Current Ratio (1.46) VS Industry: 62% outperformed.

0.00
279.52

Altman-Z (4.18) VS Industry: 77% outperformed.

-283,883.16
804.85

Dividend

Dividend Rating

8

COP has a Yearly Dividend Yield of 5.66%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.60, COP pays a better dividend.
The dividend of COP is nicely growing with an annual growth rate of 55.19%!
30.65% of the earnings are spent on dividend by COP. This is a low number and sustainable payout ratio.

COP has paid a dividend for at least 10 years, which is a reliable track record.
Compared to an average industry Dividend Yield of 5.67, COP has a dividend in line with its industry peers.
The Dividend Rate of COP has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (5.66%) VS Industry: 49% outperformed.

0.32
64.51

CONOCOPHILLIPS99.75

NYSE:COP (3/29/2023, 7:04:01 PM)+1.82 (+1.86%)

After market: 99.74 -0.01 (-0.01%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-02 2023-02-02/bmo
Earnings (Next)05-03 2023-05-03/bmo
Inst Owners82.9%
Inst Owner Change-0.77%
Ins Owners0.08%
Ins Owner Change5.9%
Market Cap121.57B
Analysts79.39
Price Target138.84 (39.19%)
Dividend
Industry RankSector Rank
Dividend Yield 5.66%
Dividend Growth(5Y)55.19%
DP30.65%
Div Incr Years6
Div Non Decr Years6
Ex-Date03-28 2023-03-28 (0.6)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.77%
Min EPS beat(2)-4.53%
Max EPS beat(2)3%
EPS beat(4)3
Avg EPS beat(4)1.78%
Min EPS beat(4)-4.53%
Max EPS beat(4)6.88%
Revenue beat(2)2
Avg Revenue beat(2)7.3%
Min Revenue beat(2)1.93%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)7.08%
Min Revenue beat(4)1.93%
Max Revenue beat(4)12.66%
PT rev (1m)-1.45%
PT rev (3m)-1.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.69%
EPS NY rev (1m)-18.1%
EPS NY rev (3m)-18.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.63%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 7.39
Fwd PE 9.26
P/S 1.55
P/FCF 6.7
P/OCF 4.29
P/B 2.53
P/tB 2.53
EV/EBITDA 3.72
EPS(TTM)13.49
EY13.52%
EPS(NY)10.78
Fwd EY10.8%
FCF(TTM)14.9
FCFY14.93%
OCF(TTM)23.23
OCFY23.29%
SpS64.4
BVpS39.39
TBVpS39.39
PEG (NY)N/A
PEG (5Y)0.09
Profitability
Industry RankSector Rank
ROA 19.91%
ROE 38.91%
ROIC 20.71%
ROICexc 23.37%
ROICexgc 23.37%
OM 32.94%
PM 23.8%
GM 47.8%
ROICexgc(3y)N/A
ROICexcg growth 3Y41.46%
ROICexcg growth 5Y55.69%
ROICexc(3y)N/A
ROICexc growth 3Y41.46%
ROICexc growth 5Y55.69%
OM growth 3Y14.86%
OM growth 5Y34.68%
PM growth 3Y2.39%
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y3.37%
F-Score8
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 0.92
Debt/EBITDA 0.5
Cap/Depr 135.38%
Profit Quality 97.19%
Current Ratio 1.46
Quick Ratio 1.36
Altman-Z 4.18
F-Score8
WACC10.38%
ROIC/WACC2.25
Cap/Depr(3y)98.21%
Cap/Depr(5y)103.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y124.83%
EPS 3Y55.47%
EPS 5Y79.2%
EPS growth Q2Q19.38%
EPS Next Y-20.11%
EPS Next 2Y-10.37%
EPS Next 3Y-11.74%
EPS Next 5Y-5.22%
Revenue growth 1Y71.28%
Revenue growth 3Y34.27%
Revenue growth 5Y21.57%
Revenue growth Q2Q22.74%
Revenue Next Year-13.91%
Revenue Next 2Y-8.08%
Revenue Next 3Y-9.67%
Revenue Next 5Y-12.9%
EBIT growth 1Y116.06%
EBIT growth 3Y54.23%
EBIT growth 5Y63.73%
EBIT Next Year2.05%
EBIT Next 3Y-4.03%
EBIT Next 5Y-6.05%
FCF growth 1Y55.54%
FCF growth 3Y59.57%
FCF growth 5Y48.83%
OCF growth 1Y66.59%
OCF growth 3Y36.62%
OCF growth 5Y31.96%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA